Literature DB >> 20930094

Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer.

Vincent Vinh-Hung1, Sue A Joseph, Nadege Coutty, Bevan Hong Ly, Georges Vlastos, Nam Phong Nguyen.   

Abstract

PURPOSE: The purpose of this article was to examine the relationship between age and lymph node ratio (LNR, number of positive nodes divided by number of examined nodes), and to determine their effects on breast cancer (BC) and overall mortality.
METHODS: Women aged ≥50 years, diagnosed in 1988-1997 with a unilateral histologically confirmed T1-T2 node positive surgically treated primary nonmetastatic BC, were selected from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER). Generalized Additive Models for Location Scale and Shape (GAMLSS) were used to evaluate the age-LNR relationship. Cumulative incidence functions and multivariate competing risks analysis based on model selection by the Bayesian Information Criterion (BIC) were used to examine the effect of age and LNR on mortality. Low LNR was defined as ≤0.20, mid-LNR 0.21-0.65, and high LNR >0.65.
RESULTS: GAMLSS showed a nonlinear LNR-age relationship, increasing from mean LNR 0.26-0.28 at age 50-70 years to 0.30 at 80 years and 0.40 at 90 years. Compared with a 9.8% [95% confidence interval (CI) 8.8%-10.8%] risk of BC death at 5 years in women aged 50-59 years with low LNR, the risk in women ≥80 years with low LNR was 12.6% [95% CI 10.1%-15.0%], mid-LNR 18.1% [13.9%-22.1%], high LNR 29.8% [22.7%-36.1%]. Five-years overall risk of death increased from 40.8% [37.5%-43.9%] by low LNR to 67.4% [61.4%-72.4%] by high LNR. The overall mortality hazard ratio for age ≥80 years with high LNR was 7.49 [6.54-8.59], as compared with women aged 50-59 years with low LNR.
CONCLUSION: High LNR combined with older age was associated with a threefold increased risk of BC death and a sevenfold increased hazard ratio of overall mortality.

Entities:  

Mesh:

Year:  2010        PMID: 20930094      PMCID: PMC3227897          DOI: 10.1634/theoncologist.2010-0044

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  56 in total

Review 1.  Neoadjuvant use of hormonal therapy in elderly patients with early or locally advanced hormone receptor-positive breast cancer.

Authors:  E Jane Macaskill; Lorna Renshaw; J Michael Dixon
Journal:  Oncologist       Date:  2006 Nov-Dec

Review 2.  Interaction between comorbidity and cancer.

Authors:  Martine Extermann
Journal:  Cancer Control       Date:  2007-01       Impact factor: 3.302

Review 3.  Clinical trials in older adults with cancer: past and future.

Authors:  Arti Hurria
Journal:  Oncology (Williston Park)       Date:  2007-03       Impact factor: 2.990

Review 4.  A short review of model selection techniques for radiation epidemiology.

Authors:  Linda Walsh
Journal:  Radiat Environ Biophys       Date:  2007-04-28       Impact factor: 1.925

Review 5.  The illness trajectory of elderly cancer patients across cultures: SIOG position paper.

Authors:  A Surbone; M Kagawa-Singer; C Terret; L Baider
Journal:  Ann Oncol       Date:  2006-10-06       Impact factor: 32.976

6.  Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis.

Authors:  Ismail Jatoi; Bingshu E Chen; William F Anderson; Philip S Rosenberg
Journal:  J Clin Oncol       Date:  2007-04-02       Impact factor: 44.544

7.  New criteria for selecting elderly patients for breast cancer adjuvant treatment studies.

Authors:  Silvia Dellapasqua; Marco Colleoni; Monica Castiglione; Aron Goldhirsch
Journal:  Oncologist       Date:  2007-08

Review 8.  Adjuvant treatment of elderly breast cancer patients.

Authors:  H B Muss
Journal:  Breast       Date:  2007-08-28       Impact factor: 4.380

9.  Prognostic value of histopathology and trends in cervical cancer: a SEER population study.

Authors:  Vincent Vinh-Hung; Claire Bourgain; Georges Vlastos; Gábor Cserni; Mark De Ridder; Guy Storme; Anne-Thérèse Vlastos
Journal:  BMC Cancer       Date:  2007-08-23       Impact factor: 4.430

10.  Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.

Authors:  Ahmedin Jemal; Elizabeth Ward; Michael J Thun
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  11 in total

1.  Potential prognostic value of the lymph node ratio and its correlation with circulating sex hormone concentration in pathological T1/2 breast cancer patients: a retrospective study.

Authors:  Wangyu Zhu; Xia Qiu; Nawa Lin; Kexin Fang; Tinglei Zhang; Naohiro Ishii; Warren Matthew Rozen; Alireza Hamidian Jahromi; Jian Huang
Journal:  Ann Transl Med       Date:  2022-05

2.  Lymph node ratio may be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2,151 patients.

Authors:  Nüvit Duraker; Bakir Bati; Zeynep Civelek Çaynak; Davut Demir
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

3.  Impact of lymph node ratio on the survival of patients with hypopharyngeal squamous cell carcinoma: a population-based analysis.

Authors:  Yu-Long Wang; Shou-Hao Feng; Ji Zhu; Guo-Pei Zhu; Duan-Shu Li; Yu Wang; Yong-Xue Zhu; Guo-Hua Sun; Qing-Hai Ji
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

4.  Prognostic value of the lymph node ratio for lymph-node-positive breast cancer- is it just a denominator problem?

Authors:  Upali W Jayasinghe; Nirmala Pathmanathan; Elisabeth Elder; John Boyages
Journal:  Springerplus       Date:  2015-03-11

5.  Association between Lymph Node Ratio and Disease Specific Survival in Breast Cancer Patients with One or Two Positive Lymph Nodes Stratified by Different Local Treatment Modalities.

Authors:  Ruoxi Hong; Zhen Dai; Wenjie Zhu; Binghe Xu
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

6.  Recursive partitioning analysis of lymph node ratio in breast cancer patients.

Authors:  Yao-Jen Chang; Kuo-Piao Chung; Li-Ju Chen; Yun-Jau Chang
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

7.  Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer.

Authors:  Bo-Wen Lei; Jia-Qian Hu; Peng-Cheng Yu; Yu-Long Wang; Wen-Jun Wei; Ji Zhu; Xiao Shi; Ning Qu; Zhong-Wu Lu; Qing-Hai Ji
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-11       Impact factor: 2.503

8.  Impact of age on the cancer-specific survival of patients with localized renal cell carcinoma: martingale residual and competing risks analysis.

Authors:  Muyan Cai; Jinhuan Wei; Zhiling Zhang; Hongwei Zhao; Yunqiao Qiu; Yong Fang; Zhenli Gao; Jiazheng Cao; Wei Chen; Fangjian Zhou; Dan Xie; Junhang Luo
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

9.  Lymph node ratio for postoperative staging of laryngeal squamous cell carcinoma with lymph node metastasis.

Authors:  Yu-Long Wang; Duan-Shu Li; Yu Wang; Zhuo-Ying Wang; Qing-Hai Ji
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

10.  Old age at diagnosis increases risk of tumor progression in nasopharyngeal cancer.

Authors:  Jing-Dun Xie; Fu Chen; Yao-Xuan He; Xiao-Di Chen; Guo-Ye Zhang; Zhi-Kun Li; Jing Hong; Dan Xie; Mu-Yan Cai
Journal:  Oncotarget       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.